PHOENIX, March 10, 2022 /PRNewswire/ -- Creative
Medical Technology Holdings, Inc. ("Creative Medical Technology" or
the "Company") (NASDAQ: CELZ), a leading commercial stage
biotechnology company focused on a regenerative approach to
immunotherapy, urology, neurology, and orthopedics, today announced
that it has signed an agreement with Cervos Inc. ("Cervos Medical")
to become the exclusive distributor of Marrow Cellution™ devices
for use in urology, gynecology, and male and female sexual
dysfunction.
"This exciting agreement provides us with exclusive access to
Cervos Medical's best-in-class devices for use in several of our
key rapid autologous therapies, including CaverStem® for erectile
dysfunction, FemCelz® for female sexual dysfunction and, upon
launch, OvaStem® for women suffering with premature ovarian
failure," said Timothy Warbington,
President and CEO of the Company. "With a guaranteed supply of high
quality devices, strong and broad IP, critical first-mover
advantages, established KOLs, and satisfied patients, Creative
Medical Technology has a wide moat and is well positioned for
success."
Harlan Adler, President of Cervos
Medical, added, "We are thrilled to expand our relationship with
Creative Medical Technology as they continue to push the
regenerative medicine market forward and showcase the many benefits
that stem cells derived from patients' bone marrow can have in
improving lives."
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage
biotechnology company specializing in stem cell technology in the
fields of immunotherapy, urology, neurology, and orthopedics. For
further information about the company, please visit
www.creativemedicaltechnology.com.
About Cervos Medical
Cervos Medical is a procedure driven medical device company
focused on innovative solutions to improve natural healing. Cervos
Medical's best-in-class autologous and synthetic orthobiologic
products mimic and promote vasculogenesis, the body's natural
reparative mechanism. Cervos Medical has developed minimally
invasive, highly efficient, and cost-effective solutions that treat
a variety of musculoskeletal conditions including growing bone,
preserving joints, and managing chronic pain. Further information
about Cervos Medical is available at www.cervos.com.
Forward Looking Statements
This news release may contain forward-looking statements
including but not limited to comments regarding the timing and
content of upcoming clinical trials and laboratory results,
marketing efforts, funding, etc. Forward-looking statements address
future events and conditions and, therefore, involve inherent risks
and uncertainties. Actual results may differ materially from those
currently anticipated in such statements. See the periodic and
other reports filed by Creative Medical Technology Holdings, Inc.
with the Securities and Exchange Commission and available on the
Commission's website at www.sec.gov.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/creative-medical-technology-secures-exclusive-distribution-rights-for-cervos-medicals-marrow-cellution-devices-for-use-in-urology-gynecology-and-male-and-female-sexual-dysfunction-301499497.html
SOURCE Creative Medical Technology Holdings, Inc.